These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32009266)

  • 1. Materials and Technologies to Combat Counterfeiting of Pharmaceuticals: Current and Future Problem Tackling.
    Zhang H; Hua D; Huang C; Samal SK; Xiong R; Sauvage F; Braeckmans K; Remaut K; De Smedt SC
    Adv Mater; 2020 Mar; 32(11):e1905486. PubMed ID: 32009266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-counterfeiting DNA molecular tagging of pharmaceutical excipients: An evaluation of lactose containing tablets.
    Altamimi MJ; Greenwood JC; Wolff K; Hogan ME; Lakhani A; Martin GP; Royall PG
    Int J Pharm; 2019 Nov; 571():118656. PubMed ID: 31499233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticounterfeit protection of pharmaceutical products with spatial mapping of X-ray-detectable barcodes and logos.
    Musumeci D; Hu C; Ward MD
    Anal Chem; 2011 Oct; 83(19):7444-50. PubMed ID: 21877684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of DNA sequences in anti-counterfeiting: Current progress and challenges.
    Sharief SA; Chahal P; Alocilja E
    Int J Pharm; 2021 Jun; 602():120580. PubMed ID: 33839229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counterfeit pharmaceuticals: current status and future projections.
    Wertheimer AI; Chaney NM; Santella T
    J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].
    Fijałek Z; Sarna K; Błazewicz A; Marin J
    Rocz Panstw Zakl Hig; 2010; 61(3):227-35. PubMed ID: 21365856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable isotope-labeled excipients for drug product identification and counterfeit detection.
    Felton LA; Shah PP; Sharp Z; Atudorei V; Timmins GS
    Drug Dev Ind Pharm; 2011 Jan; 37(1):88-92. PubMed ID: 20560792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of near-infrared spectroscopy and class-modeling to antibiotic authentication.
    Chen H; Lin Z; Tan C
    Anal Biochem; 2020 Feb; 590():113514. PubMed ID: 31785231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Counterfeit pharmaceuticals in Peru].
    Exebio LE; Rodríguez J; Sayritupac F
    Rev Panam Salud Publica; 2010 Feb; 27(2):138-43. PubMed ID: 20339618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forensic intelligence for medicine anti-counterfeiting.
    Dégardin K; Roggo Y; Margot P
    Forensic Sci Int; 2015 Mar; 248():15-32. PubMed ID: 25576676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
    Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithographically encoded polymer microtaggant using high-capacity and error-correctable QR code for anti-counterfeiting of drugs.
    Han S; Bae HJ; Kim J; Shin S; Choi SE; Lee SH; Kwon S; Park W
    Adv Mater; 2012 Nov; 24(44):5924-9. PubMed ID: 22930454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The fight against counterfeit drugs].
    Bruhn C
    Dtsch Med Wochenschr; 2013 Nov; 138(47):2396-7. PubMed ID: 24369021
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi.
    Khuluza F; Kigera S; Jähnke RW; Heide L
    Malar J; 2016 Apr; 15():215. PubMed ID: 27075749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to combat or prevent drug counterfeiting: a systematic review.
    El-Jardali F; Akl EA; Fadlallah R; Oliver S; Saleh N; El-Bawab L; Rizk R; Farha A; Hamra R
    BMJ Open; 2015 Mar; 5(3):e006290. PubMed ID: 25787989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding and fighting the medicine counterfeit market.
    Dégardin K; Roggo Y; Margot P
    J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counterfeit drugs detection by measurement of tablets and secondary packaging colour.
    Rodomonte AL; Gaudiano MC; Antoniella E; Lucente D; Crusco V; Bartolomei M; Bertocchi P; Manna L; Valvo L; Alhaique F; Muleri N
    J Pharm Biomed Anal; 2010 Oct; 53(2):215-20. PubMed ID: 20547026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016.
    Koczwara A; Dressman J
    J Pharm Sci; 2017 Oct; 106(10):2921-2929. PubMed ID: 28549909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamper-proof tablets for distinction between counterfeit and originator drugs through PEG coding.
    Ilko D; Steiger C; Keller R; Holzgrabe U; Meinel L
    Eur J Pharm Biopharm; 2016 Feb; 99():1-6. PubMed ID: 26592157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.